Authors:
Pruvost, A
Becher, F
Bardouille, P
Guerrero, C
Creminon, C
Delfraissy, JF
Goujard, C
Grassi, J
Benech, H
Citation: A. Pruvost et al., Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography tandem mass spectrometry, RAP C MASS, 15(16), 2001, pp. 1401-1408
Authors:
Paci-Bonaventure, S
Hafi, A
Vincent, I
Quertainmont, Y
Goujard, C
Charpentier, B
Taburet, AM
Citation: S. Paci-bonaventure et al., Lack of removal of nelfinavir during a haemodialysis session in an HIV-1 infected patient with hepatic and renal insufficiency, NEPH DIAL T, 16(3), 2001, pp. 642-643
Authors:
Ngo-Giang-Huong, N
Deveau, C
Da Silva, I
Pellegrin, I
Venet, A
Harzic, M
Sinet, M
Delfraissy, JF
Meyer, L
Goujard, C
Rouzioux, C
Citation: N. Ngo-giang-huong et al., Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy, AIDS, 15(6), 2001, pp. 665-673
Authors:
Goujard, C
Boufassa, F
Deveau, C
Laskri, D
Meyer, L
Citation: C. Goujard et al., Incidence of clinical lipodystrophy in HIV-1-infected patients treated during primary infection, AIDS, 15(2), 2001, pp. 282-284
Authors:
Pacanowski, J
Kahi, S
Baillet, M
Lebon, P
Deveau, C
Goujard, C
Meyer, L
Oksenhendler, E
Sinet, M
Hosmalin, A
Citation: J. Pacanowski et al., Reduced blood CD123(+) (lymphoid) and CD11c(+) (myeloid) dendritic cell numbers in primary HIV-1 infection, BLOOD, 98(10), 2001, pp. 3016-3021
Authors:
Lambotte, O
Taoufik, Y
de Goer, MG
Wallon, C
Goujard, C
Delfraissy, JF
Citation: O. Lambotte et al., Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy, J ACQ IMM D, 23(2), 2000, pp. 114-119
Authors:
Dugas, N
Dereuddre-Bosquet, N
Goujard, C
Dormont, D
Tardieu, M
Delfraissy, JF
Citation: N. Dugas et al., Role of nitric oxide in the promoting effect of HIV type 1 infection and of gp120 envelope glycoprotein on interleukin 4-induced IgE production by normal human mononuclear cells, AIDS RES H, 16(3), 2000, pp. 251-258
Authors:
Guerin, S
Meyer, L
Theodorou, I
Boufassa, F
Magierowska, M
Goujard, C
Rouzioux, C
Debre, P
Delfraissy, JF
Citation: S. Guerin et al., CCR5 Delta 32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients, AIDS, 14(17), 2000, pp. 2788-2790
Authors:
Grabar, S
Le Moing, V
Goujard, C
Leport, C
Kazatchkine, MD
Costagliola, D
Weiss, L
Citation: S. Grabar et al., Clinical outcome of patients with HIV-1 infection according to immunologicand virologic response after 6 months of highly active antiretroviral therapy, ANN INT MED, 133(6), 2000, pp. 401-410
Authors:
Labetoulle, M
Goujard, C
Frau, E
Rogier, H
Niessen, F
Furlan, V
Lantz, O
Lecointe, D
Delfraissy, JF
Offret, H
Citation: M. Labetoulle et al., Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: Incidence and outcome over 2 years, J ACQ IMM D, 22(3), 1999, pp. 228-234
Authors:
Gasnault, J
Taoufik, Y
Goujard, C
Kousignian, P
Abbed, K
Boue, F
Dussaix, E
Delfraissy, JF
Citation: J. Gasnault et al., Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy, J NEUROVIRO, 5(4), 1999, pp. 421-429
Authors:
Zou, WP
Foussat, A
Houhou, S
Durand-Gasselin, I
Dulioust, A
Bouchet, L
Galanaud, P
Levy, Y
Emilie, D
Aboulker, JP
Capitant, C
Boue, F
Bouvet, E
Karmochkinc, M
Kazatchkine, M
Oksenhendler, E
Viard, JP
Weiss, L
Yeni, P
Delfraissy, JF
Goujard, C
Jarrousse, B
Lepeu, G
Cartier, F
Bazin, C
Six, M
Gastaut, JA
Seligmann, M
Herrerra, A
Maral, J
Citation: Wp. Zou et al., Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2, AIDS, 13(4), 1999, pp. 455-463
Authors:
Martinon, F
Michelet, C
Peguillet, I
Taoufik, Y
Lefebvre, P
Goujard, C
Guillet, JG
Delfraissy, JF
Lantz, O
Citation: F. Martinon et al., Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy, AIDS, 13(2), 1999, pp. 185-194
Authors:
Geffray, L
Rosenthal, E
Cacoub, P
Perronne, C
Veyssier, P
Raguin, G
Cevallos, R
Patey, O
Bouchard, O
Loury, I
Delarocque, E
Goujard, C
Estavoyer, JM
Dupont, C
Grappin, M
Morand, P
Laurichesse, H
Vuitton, D
Citation: L. Geffray et al., The 1997 mortality rate in HIV-infected patients presenting cirrhosis due to hepatitis C virus. Results of the GERMIVIC multicenter survey conducted in the French departments of either internal medicine or infectious diseases, REV MED IN, 20(12), 1999, pp. 1082-1087
Authors:
Levy, Y
Capitant, C
Houhou, S
Carriere, I
Viard, JP
Goujard, C
Gastaut, JA
Oksenhendler, E
Boumsell, L
Gomard, E
Rabian, C
Weiss, L
Guillet, JG
Delfraissy, JF
Aboulker, JP
Seligmann, M
Citation: Y. Levy et al., Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial, LANCET, 353(9168), 1999, pp. 1923-1929
Authors:
Taoufik, Y
Gasnault, J
Karaterki, A
Ferey, MP
Marchadier, E
Goujard, C
Lannuzel, A
Delfraissy, JF
Dussaix, E
Citation: Y. Taoufik et al., Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy, J INFEC DIS, 178(6), 1998, pp. 1816-1820